Department of Internal Medicine, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
DNA Repair (Amst). 2011 Sep 5;10(9):926-33. doi: 10.1016/j.dnarep.2011.05.006. Epub 2011 Jul 16.
The X-ray repair cross complementing group 1 (XRCC1) protein is involved in DNA base excision repair and its expression varies during the cell cycle. Although studies have demonstrated that rapid XRCC1-dependent single-strand break repair (SSBR) takes place specifically during S/G(2) phases, it remains unclear how it is regulated during the cell cycle. We found that XRCC1 is a direct regulatory target of E2F1 and further investigated the role of XRCC1 in DNA repair during the cell cycle. Saos2 primary osteosarcoma cells stably transfected with inducible E2F1-wt or mutant E2F1-132E were treated with hydroxurea (HU) for 36h and were subsequently withdrawn HU for 2-24h to test whether cell-cycle-dependent DNA SSBR requires E2F1-mediated upregulation of XRCC1. We found that SSBR activity, as determined using a qPCR-base method, was correlated with E2F1 levels at different phases of the cell cycle. XRCC1-positive (AA8) and negative (EM9) CHO cells were used to demonstrate that the alterations in SSBR were mediated by XRCC1. The results indicate that E2F1-mediated regulation of XRCC1 is required for cell-cycle-dependent SSBR predominantly in G(1)/S phases. Our observations have provided new mechanistic insight for understanding the role of E2F1 in the maintenance of genomic stability and cell survival during the cell cycle. The regulation of XRCC1 by E2F1 during cell-cycle-dependent SSBR might be an important aspect for practical consideration for resolving the problem of drug resistance in tumor chemotherapies.
X 射线修复交叉互补组 1(XRCC1)蛋白参与 DNA 碱基切除修复,其表达在细胞周期中变化。尽管研究表明,快速的 XRCC1 依赖性单链断裂修复(SSBR)专门发生在 S/G2 期,但它在细胞周期中如何被调节仍不清楚。我们发现 XRCC1 是 E2F1 的直接调节靶标,并进一步研究了 XRCC1 在细胞周期中 DNA 修复中的作用。用诱导型 E2F1-wt 或突变型 E2F1-132E 稳定转染 Saos2 原代骨肉瘤细胞,用羟基脲(HU)处理 36h,随后 HU 撤出 2-24h,以测试细胞周期依赖性 DNA SSBR 是否需要 E2F1 介导的 XRCC1 上调。我们发现,使用 qPCR 基础方法测定的 SSBR 活性与细胞周期不同阶段的 E2F1 水平相关。使用 XRCC1 阳性(AA8)和阴性(EM9)CHO 细胞证明,SSBR 的改变是由 XRCC1 介导的。结果表明,E2F1 介导的 XRCC1 调节是细胞周期依赖性 SSBR 的主要 G1/S 期所必需的。我们的观察结果为理解 E2F1 在细胞周期中维持基因组稳定性和细胞存活中的作用提供了新的机制见解。E2F1 在细胞周期依赖性 SSBR 中对 XRCC1 的调节可能是解决肿瘤化疗药物耐药性问题的一个重要方面。